Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry

Heparin Scare Moves To Europe

March 2008 | Industry News

Three European countries - France, Italy and Denmark - have become the latest to recall batches of the blood-thinning drugs heparin, bringing into question how stringently active pharmaceutical ingredient (API) manufacturers from emerging markets are regulated.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Traceability To Form Large Part Of New EC Legislation

Industry Tackling the growing problem of counterfeit drugs remains a key issue within the EU and one that needs to be addressed with an increasing urgency. A delay to the European Commission (EC)'s much anticipated...
October 2008
Heparin Scare Moves To Europe

Industry Three European countries - France, Italy and Denmark - have become the latest to recall batches of the blood-thinning drugs heparin, bringing into question how stringently active pharmaceutical ingredient...
March 2008
NHS Prescribing More Obesity Drugs

Industry / United Kingdom The number of prescriptions for obesity drugs in the UK's National Health Service (NHS) has increased more than eight times since 1999 as the prevalence of the debilitating condition grow and doctors...
March 2008
NHS Prescribing More Obesity Drugs

Industry / United Kingdom The number of prescriptions for obesity drugs in the UK's National Health Service (NHS) has increased more than eight times since 1999 as the prevalence of the debilitating condition grow and doctors...
March 2008
Patent Laws Amended

Industry A new patent law, EPC2000, came into effect in the EU in December 2007, upgrading the current European Patent Convention (EPC). The revision will affect the pharmaceutical industry, as its aim is to...
January 2008
Western Europe InsightWestern Europe Channels Western Europe Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS